All Stories

  1. Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity

    Article • The FASEB Journal, April 2019, Federation of American Societies For Experimental Biology (FASEB)

    Tommaso Angelone, CARMINE ROCCA, Angelo Corti

  2. Role of NLRP-3 Inflammasome in Hypertension: A Potential Therapeutic Target

    Article • Current Pharmaceutical Biotechnology, November 2018, Bentham Science Publishers

    Professor Pasquale Pagliaro, Tommaso Angelone, CARMINE ROCCA